KAMUZU UNIVERSITY OF HEALTH SCIENCES

🇲🇼Malawi

Country: 🇲🇼Malawi

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Efficacy of Amino Acid Supplementation in Treating Environmental Enteric Dysfunction Among Children At Risk of Malnutrition

Not Applicable

Not yet recruiting

Conditions: Amino Acid, Stunting, Environmental Enteric Dysfunction

Interventions: Dietary Supplement: Corn soy bean blended flour porridge plus indispensable amino acid

First Posted Date: 2024-09-27

Last Posted Date: 2024-09-27

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 66

Registration Number: NCT06617130

Locations: 🇲🇼
Kamuzu University of Health Sciences, Blantyre, Malawi

The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children

Phase 4

Not yet recruiting

Conditions: Malaria,Falciparum

Interventions: Biological: Mosquirixs
Drug: artemether-lumefantrine

First Posted Date: 2024-05-21

Last Posted Date: 2024-05-21

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 5400

Registration Number: NCT06424002

Feasibility and Efficacy of Brief Behavior Change Counseling on Lifestyle in Hypertensive and Diabetics Participants

Not Applicable

Conditions: Hypertension
Diabetes
Life Style

Interventions: Behavioral: BBCC+5A's+GS

First Posted Date: 2020-11-12

Last Posted Date: 2020-11-12

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 50

Registration Number: NCT04625452

Locations: 🇲🇼
Mangochi District Hospital, Mangochi, Eastern-Region, Malawi

Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi

Not Applicable

Completed

Conditions: Malaria in Pregnancy

Interventions: Other: IPTp delivered by HSAs

First Posted Date: 2017-12-18

Last Posted Date: 2021-07-26

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 1447

Registration Number: NCT03376217

Locations: 🇲🇼
Malaria Alert Center, University of Malawi College of Medicine, Liwonde, Malawi

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi

Phase 3

Completed

Conditions: Malaria
Pregnancy

Interventions: Drug: dihydroartemisinin-piperaquine
Drug: Sulfadoxine-pyrimethamine

First Posted Date: 2017-01-04

Last Posted Date: 2021-07-26

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 602

Registration Number: NCT03009526

Locations: 🇲🇼
Malaria Alert Center, University of Malawi College of Medicine, Liwonde, Malawi

Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi

Phase 3

Conditions: Malaria
Severe Anemia

Interventions: Drug: dihydroartemisinin-piperaquine
Other: message(SMS) reminder
Other: short message(SMS) reminder
Other: Health worker reminder

First Posted Date: 2016-03-29

Last Posted Date: 2018-02-01

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 375

Registration Number: NCT02721420

Locations: 🇲🇼
College Of Medicine,Training and Research Unit Of Excellence,Zomba Central Hospital, Zomba, Malawi

Pneumocystis Jerovici Pneumonia in Infants and Steroids

Not Applicable

Completed

Conditions: Pneumonia, Pneumocystis Jerovici

Interventions: Drug: Prednisone
Drug: Placebo

First Posted Date: 2014-05-29

Last Posted Date: 2015-12-11

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 78

Registration Number: NCT02149433

Locations: 🇲🇼
Queen Elizabeth Central Hospital, Blantyre, Malawi

Infant Severe Sepsis and Bacterial Meningitis in Malawi

Phase 4

Completed

Conditions: Infant Bacterial Meningitis

Interventions: Drug: Ceftriaxone v penicillin and gentamicin

First Posted Date: 2010-11-25

Last Posted Date: 2016-10-26

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 351

Registration Number: NCT01247909

Locations: 🇲🇼
Queen Elizabeth Central Hospital/ College of Medicne, Private Bag 360 Blantyre, Malawi

Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis

Phase 3

Completed

Conditions: Bacterial Meningitis

Interventions: Drug: Placebo
Drug: Glycerol and paracetamol
Drug: Paracetamol
Drug: Paracetamol and glycerol
Drug: Glycerol

First Posted Date: 2008-02-20

Last Posted Date: 2012-07-10

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 466

Registration Number: NCT00619203

Locations: 🇲🇼
College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi

Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.

Phase 3

Terminated

Conditions: Convulsions
Status Epilepticus

First Posted Date: 2006-06-22

Last Posted Date: 2012-07-10

Lead Sponsor: Kamuzu University of Health Sciences

Target Recruit Count: 800

Registration Number: NCT00343096

Locations: 🇲🇼
Queen Elizabeth Central Hospital, Paediatric Dept, Box 360, Blantyre, Malawi

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy